Diana Karpman
31 – 40 of 126
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Early terminal complement blockade and C6 deficiency are protective in enterohemorrhagic Escherichia coli-infected mice
(
- Contribution to journal › Article
-
Mark
Complement contributes to the pathogenesis of Shiga toxin-associated hemolytic uremic syndrome
(
- Contribution to journal › Debate/Note/Editorial
- 2015
-
Mark
A Novel Mechanism of Bacterial Toxin Transfer within Host Blood Cell-Derived Microvesicles.
(
- Contribution to journal › Article
-
Mark
Shiga toxin-induced complement-mediated hemolysis and release of complement-coated red blood cell-derived microvesicles in hemolytic uremic syndrome.
(
- Contribution to journal › Article
-
Mark
NT-rådets ställningstagande till eculizumab är oacceptabelt
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Slutreplik, Diana Karpman och medförfattare : - NT-rådet bör omedelbart återkalla sitt beslut om eculizumab
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Complement Interactions with Blood Cells, Endothelial Cells and Microvesicles in Thrombotic and Inflammatory Conditions.
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2014
-
Mark
Eculizumab treatment for rescue of renal function in IgA nephropathy.
(
- Contribution to journal › Article
-
Mark
An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome
(
- Contribution to journal › Article
-
Mark
Enterohemorrhagic Escherichia coli Pathogenesis and the Host Response
(
- Contribution to journal › Article